Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia

Cellular Immunology

Volumn 278, Issue 1-2, 2012, Pages 91-94

  Gangemi, Sebastiano ^a,b   Allegra, Alessandro ^a   Pace, Elisabetta ^b   Alonci, Andrea ^a   Ferraro, Maria ^b   Petrungaro, Annamaria ^a   Saitta, Salvatore ^a   Gerace, Demetrio ^a   Russo, Sabina ^a   Penna, Giuseppa ^a   Musolino, Caterina ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

Essential thrombocythemia; Interleukin 10; Interleukin 22; Interleukin 23; JAK2 mutation; Polycythemia vera

Indexed keywords

HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 22; INTERLEUKIN 23; JANUS KINASE 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE MUTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; TH17 CELL; THROMBOCYTHEMIA;

AGED; FEMALE; HEMOGLOBINS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-23; INTERLEUKINS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; POLYCYTHEMIA VERA; PRURITUS; THROMBOCYTHEMIA, ESSENTIAL; THROMBOSIS;

EID: 84868278304     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.07.003     Document Type: Article

References (15)

1. Pradhan A., Lambert Q.T., Griner L.N., Reuther G.W. Activation of JAK2-V617F by components of heterodimeric cytokine receptors. J. Biol. Chem. 2010, 285:16651-16663.
2. Manshouri T., Estrov Z., Quintás-Cardama A., Burger J., Zhang Y., Livun A., Burger J., Zhang Y., Livun A., et al. Bone marrow stroma-secreted cytokines protect JAK2(V617F)-mutated cells from the effects of a JAK2 inhibitor. Cancer Res. 2011, 71:3831-3840.
3. Betts B.C., Abdel-Wahab O., Curran S.A., Angelo E.T. St., Koppikar P., Heller G., Levine R.L., Young J.W. Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen. Blood 2011, 118:5330-5339.
4. Romagnani S., Maggi E., Liotta F., Cosmi L., Annunziato F. Properties and origin of human Th17 cells. Mol. Immunol. 2009, 47:3-7.
5. Wilson N.J., Boniface K., Chan J.R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 2007, 8:950-957.
6. Brunsing R.L., Prossnitz E.R. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1. Immunology 2011, (Epub ahead of print). 10.1111/j.1365-2567.2011.03471.x.
7. Chien M.H., Hsin C.H., Shih-Shen Chou L., Chung T.T., Lin C.H., Weng M-S., Chou M.Y., Chen M.K., Yang S.F. Interleukin-23 receptor polymorphism as a risk factor for oral cancer susceptibility. Head Neck 2011, Epub ahead of print. 10.1002/hed.21779.
8. S. Gangemi, A. Allegra, A. Alonci, E. Pace, A. Cannavò, M. Ferraro, G. Penna, S. Saitta, D. Gerace, C. Musolino, Interleukin 22 is increased and correlated with CD38 expression in patients with B-Chronic Lymphocytic Leukemia, Blood Cell Mol. Dis., in press.
9. Musolino C., Allegra A., Ferraro M., Aguennouz M., Russo S., Alonci A., Saitta S., Gangemi S. Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients. Acta Oncol. 2011, epub ahead of print.
10. Adamo V., Franchina T., Minciullo P.L., Pace E., Colonese F., Ricciardi G.R., Saitta S., Ferraro M., Spatari G., Gangemi G. Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives. J. Cell Physiol. 2011, 226:3032-3034.
11. Hus I., Tabarkiewicz J., Lewandowska M., Wasiak M., Wdowiak P., Kusz M., Legiec M., Dmoszynska A., Rolinski J. Evaluation of monocyte-derived dendritic cells T regulatory and Th17 cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Folia Histochem. Cytobiol. 2011, 49:153-160.
12. Che Mat N.F., Zhang X., Guzzo C., Gee K. Interleukin-23-induced interleukin-23 receptor inpathway in human CD4 T cells. J. Interferon Cytokine Res. 2011, 31:363-371.
13. Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 2007, 117:1175-1183.
14. Wang L., Yi T., Kortylewski M., Pardoll D.M., Zeng D., Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. JEM 2009, 206:1457-1464.
15. Pieri L., Bogani C., Guglielmelli P., Zingariello M., Rana R.A., Bartalucci N., Bosi A., Vannucchi A.M. The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera. Haematologica 2009, 94:1537-1545.